Atlantic Bloom, Inc. is the SPV for Premium Cannabis Cultivation Co.

CANNCO

*

Pioneering 3,500lbs/Month

of Hand-Trimmed Flower in to Meet Explosive Demand

Atlantic Bloom SPV is a Special Purpose Vehicle structured to anonymously raise seed funds for a premium cannabis cultivation company (referred to herein as ‘CannCo’ for confidentiality). Upon establishing initial investor interest and execution of a non-disclosure agreement (NDA), we will disclose the real corporate names, full business details, and access to the data room.

01. The Opportunity

Atlantic Bloom SPV, through CannCo, will produce 42k lbs/year of premium hand-trimmed cannabis flower in an 85k sqft facility using advanced hydroponics, IPM, and LED tech (0.7g/watt).

However, high-quality hand-trimmed flower remain scarce in $300-450M market, with dispensaries facing supply shortages and inconsistent quality.

02. Growth Drivers

  • Rising wholesale demand ($3,200/lb): With over 60 new dispensaries opening statewide, demand for premium flower remains incredibly high amid persistent supply shortages.
  • Competitors lag in scale and efficiency: Most cultivators are micro-scale operations, unable to match our large-scale, high-tech facility—leaving the 60% premium segment underserved and creating a $60M TAM/SAM opportunity (20% share potential).

$60M opportunity.

TAM/SAM: 20% share potential

03. Strategic Dispensary Partnership

Atlantic Bloom SPV, through CannCo, has secured a pending first-of-its-kind dispensary partnership strategically located in the lobby of a premier hotel directly across from one of the largest casinos in the eastern United States. This innovative retail outlet will capitalize on high-traffic tourism, ensuring robust offtake for our premium hand-trimmed flower and driving immediate revenue streams.

  • Key Advantages: Captive audience of millions of annual visitors, enabling retail margins ($10–15/g vs. wholesale $3,200/lb) and brand visibility in growing $300–450M market.
  • Significance: As a pioneering hotel-lobby dispensary, this positions CannCo for 20%+ market share in the premium segment, mitigating supply chain risks with direct-to-consumer sales.
  • Status: Pending final regulatory approvals; expected to accelerate our path to $60M TAM opportunity.
This partnership underscores our edge in a competitive market—high-traffic, low-risk demand.
Confidential – For Discussion Purposes Only. Projections are estimates. October 30, 2025.

CANNCO

Solutions and Operations

04. Project Goal

CannCo will cultivate 42,000 lbs/year of premium flower in an 85,000 sq ft facility using advanced hydroponics, IPM, and LED tech for optimal yields (0.7g/watt). Our focus on curated, hand-crafted products with distinctive terpene profiles will create unique branding opportunities, fostering a loyal customer following through superior quality and personalized experiences. By prioritizing quality connections with customers, we ensure consistent, high-end flower that stands out in the market. As the COO will also serve as developer, the company will directly manage the construction buildout, ensuring lean execution, cost efficiencies, and alignment with investor goals—avoiding third-party mark-ups and reducing overruns typical in outsourced engineering.

05. Key milestones

  • Secure $3M regulatory application, site LOI, and approvals within 6 months.
  • Lease Partner: Equity/rev share for facility responsibility, minimizing upfront capex.
  • Scalability: Phased rollout to full 3,500 lbs/month production.
  • Dispensary Partnership: Pending first-of-its-kind retail store in a hotel lobby opposite a major U.S. casino, ensuring high-traffic offtake.

$4M Seed Round

via Convertible Notes/SAFE ($10–15M Valuation Cap, 10–20% Discount)

06. Financials

  • Projections:$20-40M annual revenue at scale; 25%+EBITDA margins by Year 3.
  • ROI & IRR: Targeting 3-5x ROI(25-40% IRR) via scenarios tied to 750M market growth by 2026.
  • Holding period: 5-7 years, with potential acceleration from 2025 MSO consolidation
  • Exit: Primary via acquisition by leading MSOs (e.g., Curaleaf, Trulieve) at 5-10x multiples; alternatives include IPO or uplisting to NYSE/NASDAQ amid 2025 federal rescheduling, potentially unlocking 8-12x revenue valuations as seen in peers like Tilray.
  • Consultants/Legal
  • Initial Ops
  • Grow Facilities Site planning
  • Reserves

Our Team

Led by experienced operators with a track record in agriculture and cannabis.

CANNCO

Our Team

Led by experienced operators with a track record in agriculture and cannabis.

CANNCO

CEO:

Current dispensary owner with 20+ years in medical cannabis advocacy/consulting; agribusiness scaling operations.

Director Of Cultivation

25+ years in optimizing large-scale commercial cannabis operations from 10,000 to 500,000 SF across indoor and greenhouse environments. MSO expertise with leadership in crop steering, facility design and team leadership.

Advisors

Cannabis attorney, agronomist, investment banker.

COO: Eric Purnell

29+ years executive leadership in pre-operations planning, capital raising, M&A/IPO readiness, and real estate development; Managed $12.7B in construction programs (including cannabis and environmental projects); 12 years in biomedical VC evaluating startups via due diligence; Proven in layering equity/debt funding, governance/compliance, and transforming teams into investor-ready organizations.

Risks & Next Steps

Key Risks: Regulatory delays (mitigated by backups and expert counsel); market volatility (via offtake agreements).

Get in touch for full teaser, or access data room

SPV & Disclosure: Atlantic Bloom, a SPV (special purpose vehicle), is authorized solely to raise funds for contribution to a newly licensed large-scale premium cannabis cultivation company in Co The company’s identity will be disclosed to interested investors under NDA upon establishing initial engagement.